Heroin, also known as diacetylmorphine, is a very efficient prodrug and more potent than Morphine. Many deaths are caused by heroin overdoses throughout the world each year. Heroin, which can be sniffed, smoked or injected, is experiencing a rebound in usage, partially related to the efforts to reduce the abuse of prescription pain relievers.With increased usage there has been a corresponding increase in overdose related deaths. For heroin-related death rates, 14 states in USA had significant increases, with Washington D.C., West Virginia and Ohio having the highest rates. Heroin is one of the most commonly used drugs among intravenous drug abusers. Conventionally, chemical compounds that are fractionated from the juice of the opium poppy (Papaver somniferum) are known as opiates. Similarly, acting synthetic chemical compounds are known as opioids. The predominant opiate found in opium poppy juice. The juice of the opium poppy is harvested, which contains a variety of opiates, mostly morphine. Additional processing is necessary to refine the opium poppy liquid into heroin. Heroin is synthesizied from morphine by acetylation at both 3 snd 6 position and metabolized in the human body to active opioid compounds first by deacytilation to 6 Mono acetyl morphine (6MAM) then by further deacytilation to Morphine. Heroin is smaller per dose, making it the version of the product preferred by drug smugglers. 
Heroin is usually used as an illegal drug of abuse. In rare settings, heroin is prescribed by doctors for pain control. Heroin given intramuscularly is about two times as potent for pain relief. Heroin is not allowed to be prescribed by doctors in the United States, but prescription heroin is available in rare settings in other countries. Heroine has an average half life of three minutes in blood after intravenous administration but half-life of 6-acetyl morphine in human is about 30 minutes. Heroine peak blood level happens after 5 minutes of usage intranasally or intravenously but its potency after intranasal usage is about half of intravenous usage.
Because of various economic and social factors, heroin is one of the most commonly abused opioids in the world today. In 2012, annual prevalence rates for heroin use without a needle were 0.3% for 8th grade students and 0.4 percent for 10th and 12th grade students. For all grades, annual prevalence use of heroin with a needle was 0.4%. Heroin related emergency department visits have increased from 33,900 in 1990 to 213,118 in 2009. Heroin related overdose deaths increased from 2300 in 1991 to 15.958 in 2017. There was a 7 fold increase in the total number of heroin overdose deaths in this period.
The most recent classification scheme identifies three major classes of opioid receptor, with several minor classes. The three most clinically relevant opioid receptors are the mu, kappa and delta receptors. Stimulation of central mu receptors causes respiratory depression, analgesia (supraspinal and peripheral), and euphoria. Kappa and delta opioid receptors also have potent analgesic effects, with the kappa receptors being known for causing disassociation, hallucinations, and dysphoria and Delta receptors also modulates of mu receptors and are thought to influence mood.Heroin has effects on the opioid receptors, particularly the mu receptor. It also has effects on the kappa and delta receptors. There is an evolving body of knowledge that the intensity and quality of response to heroin and other opioids can vary significantly between patients which can be unrelated to tolerance.
Heroin is a strong agonist of opioid receptors. As mentioned, Heroin has a short half-life, requiring drug abusers to use it several times per day to maintain the effect. Additionally, tolerance usually develops over time, requiring consumers to take stronger and stronger doses to get the same effect. Tolerance to respiratory depression may be slower than tolerance to euphoric effects. The level of tolerance to opioid can have significant effects on an individual's risk of opioid overdose. Overdose is common as a consumer rarely knows how much they are taking per purchased dose. Also, in street drugs, there are often contaminants that dilute the percentage of the drug consumed.
Heroin's half-life is so short that consumers are usually seen medically in the setting of either overdose or withdrawal. In the overdose setting, there is usually decreased respiratory effort and rate, with sedation and constricted pupils. A severe overdose can progress to apnea with coma, which is followed by minutes by cardiac arrest and death unless immediate rescue measures are taken. Heroin withdrawal is often associated with alertness, muscle pain, dilated pupils, piloerection, sweating, intestinal distress (like vomiting, diarrhea),joint pain, insomnia and yawning. opiate withdrawal symptoms are not life threatening like alcohol or benzodiazepine withdrawal. Some or all of these symptoms may be seen; the patient does not need all to be diagnosed with heroin withdrawal. In summary, several medications can be used to treat opiate withdrawal symptoms like Methadone (long acting opioid), Buprenorphine (partial mu agonist and Kappa antagonist) or alpha-2 adrenergic agents (clonidine and Lofexidine). If there is intravenous use, there can be "track marks." These are very small abrasion type skin changes overlying veins, usually in the extremities, but infrequently can also be found in the neck and other anatomic locations. Intravenous drug use can lead to infectious complications that are discussed elsewhere (such as cellulitis, thrombophlebitis, endocarditis, septic emboli and compartment syndrome for example). Adulterants in heroin can be quite diverse and sometimes unknown to the consumer and can confound the evaluator by giving a potentially very broad spectrum of conflicting physical exam findings. Law enforcement may have knowledge of the current adulterant blend of the heroin that is being locally consumed at the time of the encounter.
The evaluation is clinical, with prioritization of airway and breathing in the overdose setting. Urine drug screening is thought to not be useful in the acute setting but has value in surveillance (employment screening) or recovery (drug rehab) setting. On urine drug testing, heroin makes the "opioids" line positive, along with morphine, codeine, hydromorphone, and hydrocodone. Other opioids usually do not turn this test positive and need to be tested for separately, including methadone, oxycodone, fentanyl, buprenorphine, and tramadol. Bedside/office urine cup drug screens have (infrequent) false positive and false negative results for a variety of substances tested for. The only finding in the urine that proves heroin use is the detection of 6-MAM (6 mono acetylymorphine). This metabolite is specific byproduct of heroin metabolism. 6MAM is eliminated in the urine quickly and is detected for less than 8 hours after heroin abuse. Gas chromatography and mass spectroscopy (GCMS) testing can be used for a definitive answer if there is a conflict between the patient and the provider regarding the truth or falsehood of the urine drug test result. Medical Review Officers control the information obtained during employment-related drug testing in the United States.
In the heroin overdose setting, hypopnea (breathing that is ineffectively slow and/or shallow) can progress to apnea. Naloxone is a mainstay of therapy in this setting, but the practitioner is warned that first line treatment is control of the airway and rescue breathing. Bag valve mask ventilation or similar intervention should be initiated immediately by the primary rescuer to restore oxygen supply to vital organs while other rescuers evaluate available methods of naloxone administration. A single rescuer should focus on providing oxygen to the overdose victim until other rescuers are available to assist. Basic Life Support and Advanced Cardiac Life Support principles should be followed during the resuscitation of a heroin overdose. Adequate intravenous access is necessary so enough fluids and medication can be administered. An initial intravenous dose of 0.4 to 0.8 mg of naloxone will quickly reverse neurologic and cardiorespiratory symptoms. Frequent monitoring of vital signs and cardiorespiratory status is needed to make sure Heroin is cleared from the patient system.Patients who were treated with naloxone after heroin overdose may be safely released without transport to the hospital or emergency room if they have normal mentation and vital signs. In the absence of co-intoxicants and further opioid use there is a very low risk of death from rebound heroin toxicity.
Clinician who manage overdose patients should establish the need for ongoing addiction treatment. In the absence of acute medical and psychiatric complications, the patient can be discharged from the hospital and can be referred for addiction care (like out patient counseling and maintenance treatment with methadone or buprenorphine or naltrexone).
In addition to efforts to improve the treatment of overdoses in the ED(emergency department) and healthcare facility settings, efforts have begun to educate the lay public about the early recognition and treatment of overdoses.This includes efforts to ensure improved access to naloxone for management of overdoses, including its usage by the lay public, and efforts to encourage the public to access ED earlier when an overdose is suspected. it is useful to implement policies which allow licensed providers to prescribe naloxone to patients using opioids or other individuals in close contact with those patients. Also, any individuals who administer naloxone should be protected from prosecution for practicing medicine without a license.
Heroin use, abuse, overdose, and addiction have had many discussions in the professional and lay press of the United States, which intensified in the 2000s and 2010s. After around 2012 the United States government began to shift prioritization of money from interdiction and law enforcement to treatment programs to treat drug addicts including those addicted to heroin. This focus shift was brought about by several factors. One factor was a growing recognition that interdiction efforts, in what was known commonly as the drug war, were not yielding results equivalent to the effort and money invested. There was also growing professional, and lay acceptance of the concept of medication assisted treatment, involving replacing the heroin with another full agoist opioid such as methadone or partial opioid agonist like buprenorphine. A growing body of evidence began to show more clearly that medication assisted treatment when added to traditional abstinence efforts suppressed relapse risk more effectively than abstinence efforts alone. As of 2016, there was ongoing sometimes heated debate regarding if medication assisted treatment was exchanging one drug for another, as was asserted by some addiction treatment leaders of the time, and if that were true, what ethical ramifications that presented to the practitioner. The trend of consensus, where that could be obtained, was that the benefits of harm reduction with the initiation of medication assisted treatment outweighed the risks in someone verified to be a patient with recurrent, problematic, accelerating use of opioids.